Results 51 to 60 of about 2,542 (110)

Massive circulating metastatic cells: A case of carcinocythemia

open access: yesClinical Case Reports
Key Clinical Message Importance of careful differential diagnosis to make the distinction between carcinocythemia and acute leukemia or lymphoma.
Carine Farkh   +3 more
doaj   +1 more source

Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy

open access: yesHaematologica, 2018
Evading immune eradication is a prerequisite for neoplastic progression and one of the hallmarks of cancer. Here, we review the different immune escape strategies of lymphoma and classify them into two main mechanisms. First, lymphoma cells may “hide” to
Marie de Charette, Roch Houot
doaj   +1 more source

P-084: INFECTIOUS PROFILE OF SICKLE CELL PATIENTS IN THE HEMATOLOGY DEPARTMENTS OF CONAKRY UNIVERSITY HOSPITAL

open access: yesHemaSphere, 2022
DIAKITE M.   +4 more
doaj   +1 more source

Exploring the needs and resources of children in a haematology-oncology unit

open access: yesHealth SA Gesondheid: Journal of Interdisciplinary Health Sciences, 2011
Too often a child’s body is restored to health in the hospital, but the child is sent home with emotional wounds. This study explored the needs of children in a haematology-oncology unit as well as the resources that could be mobilised in order to ...
Annemarie E. Oberholzer   +3 more
doaj   +1 more source

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15− cells in early chronic‐phase chronic myeloid leukemia

open access: yesMolecular Oncology, 2018
Despite the high efficiency of tyrosine kinase inhibitors (TKI), some patients with chronic myeloid leukemia (CML) will display residual disease that can become resistant to treatment, indicating intraclonal heterogeneity in chronic‐phase CML (CP‐CML ...
Stéphanie Maupetit‐Mehouas   +14 more
doaj   +1 more source

B01 VENETOCLAX TARGETED THERAPY in AL AMYLOIDOSIS PATIENTS: A RETROSPECTIVE ANALYSIS FROM THE FRENCH AMYLOIDOSIS NETWORK

open access: yesHemaSphere, 2023
M. Roussel   +19 more
doaj   +1 more source

Posterior reversible encephalopathy syndrome (PRES) and myeloma

open access: yesLeukemia Research Reports
Posterior reversible encephalopathy syndrome (PRES) has rarely been described in myeloma, but chemotherapy is a known risk factor. We report 3 patients with myeloma who developed PRES, and analyzed them with 13 published cases, mostly women.
Ricardos Ghanem   +7 more
doaj   +1 more source

Evaluation externe de la qualité de la numération des lymphocytes T-CD4 au laboratoire d'immunologie et hématologie du CHU de Cocody

open access: yesThe Pan African Medical Journal, 2018
INTRODUCTION: Le taux de lymphocytes T-CD4 (LT4) est un paramètre crucial de suivi et de décision thérapeutique au cours de l'infection au Virus de l'Immunodéficience Humaine (VIH). Sa détermination doit être fiable et précise. Pour fournir des résultats
Koffi N’guessan   +4 more
doaj   +1 more source

The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohort

open access: yesHaematologica
In chronic myeloid leukemia, the identification of early molecular predictors of stable treatment-free remission (TFR) after tyrosine kinase inhibitor (TKI) discontinuation is challenging.
Sandrine Saugues   +14 more
doaj   +1 more source

Chronic sinusitis in a patient with selective IgG4 subclass deficiency controlled with enriched immunoglobulins

open access: yesClinical Case Reports, 2017
Key Clinical Message A 71‐year‐old female patient with no major history of infection had presented with recurrent chronic purulent sinusitis over the past 3 years.
Gérard Dine   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy